• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC UNK_THERMOCOOL SF NAV; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC UNK_THERMOCOOL SF NAV; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number UNK_THERMOCOOL SF NAV
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problems Ventricular Fibrillation (2130); Pericardial Effusion (3271); Heart Block (4444)
Event Date 11/13/2021
Event Type  Death  
Manufacturer Narrative
This complaint is from a literature source.The following literature cite has been reviewed: rabah h, youness m, rabah a.Sensor enabled catheter ablation study (secas).Cureus.2021 nov 13;13(11):e19550.Doi: 10.7759/cureus.19550.Pmid: 34926037; pmcid: pmc8671080.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer¿s reference number: (b)(4).
 
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: rabah h, youness m, rabah a.Sensor enabled catheter ablation study (secas).Cureus.2021 nov 13;13(11):e19550.Doi: 10.7759/cureus.19550.Pmid: 34926037; pmcid: pmc8671080.Objective/methods/study data: background: ensite precision technology (abbott, (b)(4) is a novel mapping and navigation system facilitating the visualization and manipulation of intracardiac catheters during arrhythmia ablation procedures.When using sensor enabled (se) catheters (abbott, (b)(4)), the mapping system uses both electrical impedance and magnetic data to facilitate more accurate mapping and navigation.Whether this translates into better clinical outcomes is unknown.Methods: this retrospective study will examine whether se catheters improve the success rate or decrease the risks compared to biosense thermocool catheters (biosense webster inc., (b)(4)) not employing sensor-enabled technology utilizing navx ensite precision algorithms.Charts of 146 patients who underwent radiofrequency ablations for supraventricular and ventricular arrhythmias between 2016 and 2019 in the (b)(6) were reviewed and analyzed.It was concluded that se catheters have the same success rate as electrical impedance catheters.Results: a total of 70% of the ablations carried using the impedance-based catheter were successful compared to 74% using the se catheter.However, the difference was statistically non-significant (p-value: 0.7).As for complications, the ventricular fibrillation rate was increased in the se catheter group.Three procedures were complicated by pericardial effusion, three patients had reversible heart block, and one death was recorded, all reported while using the standard catheter (p-value: 0.01).-conclusion: se catheters have the same success rates compared to standard catheters using the ensite precision mapping system.Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: thermocool; other biosense webster devices that were also used in this study: n/a.Non-biosense webster devices that were also used in this study: ensite precision technology (abbott, (b)(4)); a sensor enabled (se) catheter (abbott, (b)(4)); navx se field scalin.Adverse event(s) and provided interventions: three patients had ventricular fibrillation (vf) requiring cardioversion; two procedures were complicated by pericardial effusion; three patients had reversible heart block; one death was recorded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_THERMOCOOL SF NAV
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key14649958
MDR Text Key293683591
Report Number2029046-2022-01250
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_THERMOCOOL SF NAV
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/20/2022
Initial Date FDA Received06/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
A SENSOR ENABLED (SE) CATHETER (ABBOTT); ENSITE PRECISION TECHNOLOGY (ABBOTT,); NAVX SE FIELD SCALIN
Patient Outcome(s) Life Threatening; Death;
-
-